Lucene search

K
cve[email protected]CVE-2007-6763
HistoryJul 31, 2019 - 6:15 p.m.

CVE-2007-6763

2019-07-3118:15:10
CWE-20
web.nvd.nist.gov
45
sas
drug development
sdd
32drg02
logout
access control
security vulnerability

6.5 Medium

CVSS2

Attack Vector

NETWORK

Attack Complexity

LOW

Authentication

SINGLE

Confidentiality Impact

PARTIAL

Integrity Impact

PARTIAL

Availability Impact

PARTIAL

AV:N/AC:L/Au:S/C:P/I:P/A:P

8.8 High

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

8.5 High

AI Score

Confidence

High

0.001 Low

EPSS

Percentile

40.1%

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Affected configurations

NVD
Node
sassas_drug_developmentRange<32drg02

6.5 Medium

CVSS2

Attack Vector

NETWORK

Attack Complexity

LOW

Authentication

SINGLE

Confidentiality Impact

PARTIAL

Integrity Impact

PARTIAL

Availability Impact

PARTIAL

AV:N/AC:L/Au:S/C:P/I:P/A:P

8.8 High

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

8.5 High

AI Score

Confidence

High

0.001 Low

EPSS

Percentile

40.1%

Related for CVE-2007-6763